01:05:43 EDT Thu 01 Jun 2023
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Titan Medical Inc (2)
Symbol TMD
Shares Issued 111,202,690
Close 2022-05-02 C$ 0.56
Recent Sedar Documents

Titan Medical receives $2.6M order from Medtronic

2022-05-03 10:13 ET - News Release

Mr. Paul Cataford reports

TITAN MEDICAL ANNOUNCES PURCHASE ORDER FROM MEDTRONIC

Titan Medical Inc. has a receipt of a $2.6-million purchase order from Medtronic PLC, a global leader in health care technology.

The order covers the purchase of instruments and cameras that will be used in preclinical activities and the evaluation of Titan Medical as a potential manufacturing and supply partner for Medtronic.

"Medtronic has been a great partner for Titan since 2020 and we're excited about this opportunity to further our work together," said Paul Cataford, interim president and chief executive officer of Titan. "Our manufacturing team and capabilities continue to expand at our operations in Chapel Hill. With this order, we will produce instruments and cameras for Medtronic's evaluation and testing in addition to producing instruments and cameras for our own single-access RAS platform, Enos."

For clarity, these agreements are between Medtronic and Titan Medical. Titan Medical is not affiliated with Titan Spine, which Medtronic acquired in 2019.

About Titan Medical Inc.

Titan Medical, a medical device company headquartered in Toronto, Ont., with operations in Chapel Hill, N.C., is focused on enhancing robotic-assisted surgery (RAS) using innovative technology through a single access point. The Enos robotic single access surgical system is being developed with an ergonomic focus to provide a surgical experience that imitates real-life movements that surgeons demand. The Enos system includes multiarticulating instruments designed to allow surgeons an increased range of motion in a confined space, with dexterity and the ability to exert the forces necessary to complete common surgical tasks. Titan intends to initially pursue gynecologic surgical indications with the Enos system.

We seek Safe Harbor.

© 2023 Canjex Publishing Ltd. All rights reserved.